Apreo Health has raised $130 million in a Series B financing round, led by Bain Capital Life Sciences and Norwest, to support pivotal trial and commercialization of its airway scaffold for severe emphysema.
Amount Raised
$130 Million
Round Type
Series B
Menlo ParkBiotechnologyHealth CareMedicalmedical devicesInvestors
Description
Apreo Health, a clinical-stage medical device company, announced the closing of an oversubscribed $130 million Series B financing round. The funding will support the BREATHE-3 trial, aimed at evaluating the safety and efficacy of their airway scaffold. New investors included Bain Capital Life Sciences and Norwest, with participation from others. This financing represents a significant milestone for the development of innovative treatments for severe emphysema.
Quick answer
Apreo Health raised $130 Million in a Series B round, dated August 7, 2025. Investors: Norwest Venture Partners, F Prime, Intuitive Ventures, Lightstone Ventures, Santé Ventures and Bain Capital Life Sciences. Apreo Health is based in Menlo Park, California, United States.
- How much did Apreo Health raise?
- Apreo Health raised $130 Million in a Series B round on August 7, 2025.
- Who invested in Apreo Health?
- Norwest Venture Partners, F Prime, Intuitive Ventures, Lightstone Ventures, Santé Ventures and Bain Capital Life Sciences are named as investors in this round.
- What does Apreo Health do?
- Apreo Health is redefining interventional pulmonology with a non-destructive, tissue-sparing solution for severe emphysema—one of the most under-treated and misunderstood diseases in medicine.
- Where is Apreo Health based and how big is it?
- Apreo Health is based in Menlo Park, California, United States. Fundz records about 22 employees.
- Who are the decision-makers at Apreo Health?
- Fundz holds 1 contact at Apreo Health. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and medical devices around the same time
Companies in the same sectors as Apreo Health that raised within 45 days of this round, from Fundz verified event records.
- Ronovo Surgical raised $67M (Series D) on September 5, 2025.
- Sophont raised $9.2M (Seed) on September 11, 2025.
- Noxilizer raised $30M (Funding Round) on September 10, 2025.
- MadSci raised $10M (Seed) on September 8, 2025.
- AI Technology Group raised $2M (Seed) on September 5, 2025.
- Compact Medical raised $200K on September 2, 2025.
Who to call at Apreo Health, and when
A new round usually means Apreo Health is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Apreo Health raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Apreo Health, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Apreo Health. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Apreo Health raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansApreo Health raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.